Filing Details

Accession Number:
0001209191-20-003510
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-15 18:23:06
Reporting Period:
2020-01-13
Accepted Time:
2020-01-15 18:23:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324991 L James Tyree C/o Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-13 15,285 $36.69 20,060 No 4 S Direct
Common Stock Disposition 2020-01-13 14,715 $37.44 5,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $36.20 to $37.19 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $37.20 to $38.00 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.